Daiichi Sankyo is no longer best understood as a successful Japanese pharma company with a strong […]
Japan is one of the world’s most demanding healthcare markets. It is also one of the […]
For too long, if you ask me, the Japan pharmaceutical market opportunity has been treated as […]
Entering Japan is not only about regulatory approval, launch planning, and commercial ambition. One of the […]
On December 12, 2025, Japan’s Ministry of Health, Labour and Welfare (MHLW) tabled a draft outline […]
Cracking Japan’s Pharma Ecosystem: Field Notes from ~20 Years in the Trenches Japan rewards sequencing, proof, […]
As mRNA biotechnology matures, few firms have demonstrated a shift as dynamic as Moderna. Widely recognised […]
In the mid-1990s, Japan was not merely participating in the global pharmaceutical industry—it was shaping it. […]
From Automation to Inflexion: AI’s Historical Trajectory in Pharma The pharmaceutical industry began its journey with […]